A double-edge sword: the role of D-chiro-inositol in oocyte and embryo quality
International Journal of Medical Device and Adjuvant Treatments · 2019-12 · 2
DOI: 10.32113/ijmdat_201912_208 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Device and Adjuvant Treatments, 2019-12. Verfasst von M. Minini und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
D-chiro-inositol is one of the nine stereoisomers of inositol, a water-soluble cyclic carbohydrate with six hydroxyl groups. Inositol has an essential function in the activation of crucial enzymes in glucose metabolism. In fact, D-chiro-inositol shortage can lead to insulin resistance development. D-chiro-inositol administration in pathologies where insulin resistance is an important factor, i.e. diabetes, has given satisfying results; however, in other disorders, i.e. Polycystic ovary syndrome, this stereoisomer can be detrimental for pregnancy. Indeed, high follicular D-chiro-inositol levels in the presence of reduced myo-inositol values are associated with worsened oocyte quality. In conclusion, some recent studies and researches suggest that restoring the physiologic ratio between myo-inositol and D-chiro-inositol is mandatory to protect the efficiency of the reproductive system in women.
Schlagwörter
Zitieren
APA
Minini, M., Monastra, G., & Dinicola, S. (2019). A double-edge sword: the role of D-chiro-inositol in oocyte and embryo quality. International Journal of Medical Device and Adjuvant Treatments, 2. https://doi.org/10.32113/ijmdat_201912_208
Vancouver
Minini M, Monastra G, Dinicola S. A double-edge sword: the role of D-chiro-inositol in oocyte and embryo quality. International Journal of Medical Device and Adjuvant Treatments. 2019;2. doi:10.32113/ijmdat_201912_208
BibTeX
@article{Minini2019,
author = {Minini, M. and Monastra, G. and Dinicola, S.},
title = {A double-edge sword: the role of D-chiro-inositol in oocyte and embryo quality},
journal = {International Journal of Medical Device and Adjuvant Treatments},
year = {2019},
volume = {2},
doi = {10.32113/ijmdat_201912_208}
}
EUVIMED